2017年4月13日星期四

Direct to Consumer Genetic Testing: Risks and Opportunities

Accurate genetic testing stands to transform modern medicine by offering effective, personalized treatment. Last week, the U.S. Food and Drug Administration (FDA) authorized marketing of the first direct-to-consumer (DTC) genetic health risk (GHR) tests. Individuals in the U.S. can now …

from News – Insurance Journal

没有评论:

发表评论